Trial Profile
Clinical study to investigate the effects of mitiglinide add-on therapy with pioglitazone in patients with type 2 diabetes and cardiovascular disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2012
Price :
$35
*
At a glance
- Drugs Mitiglinide (Primary) ; Pioglitazone (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 06 Dec 2012 New trial record